Meeting
2021 Genitourinary Cancers Symposium
Association of the neutrophil to eosinophil ratio with response to immunotherapy-based combinations in metastatic renal cell carcinoma.
Presenter
Matthew D Tucker, MD
Vanderbilt University Medical Center
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 341)
DOI
10.1200/JCO.2021.39.6_suppl.341
Abstract #
341
Poster Bd #
Online Only
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2021 ASCO Annual Meeting
Association of baseline neutrophil-to-eosinophil ratio (NER) and neutrophil-to-lymphocyte ratio (NLR) with response to combination immunotherapy (IO) with ipilimumab plus nivolumab (ipi/nivo) in patients with metastatic renal cell carcinoma (mRCC).
Speaker: Matthew D. Tucker, MD
Videos & Slides
2023 ASCO Annual Meeting
A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma.
Speaker: Yuval Shaked, PhD, BSc
Videos & Slides
2023 ASCO Genitourinary Cancers Symposium
Effect of treatment of residual disease after immunotherapy-based combinations on complete response rate in metastatic renal cell carcinoma.
Speaker: Fabien Moinard-Butot, MD
Videos & Slides
2022 ASCO Genitourinary Cancers Symposium
A multicenter real-world study reviewing systemic anticancer treatment choices and drop off rates between treatment lines for metastatic renal cell carcinoma in the United Kingdom: In the immunotherapy era.
Speaker: John McGrane, MBChB MRCP FRCR